The Natural Product Corramycin Acts as a DNA Gyrase Poison and Overcomes Fluoroquinolone Resistance in Mycobacterium

Franziska Fries1,2, Jennifer Herrmann1,2, Michael Dal Molin3,4,5

  • 1Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI) and Department of Pharmacy, Saarland University, Saarbrücken, Germany.

Insights

Corramycin, a novel natural product, shows potent activity against drug-susceptible and -resistant tuberculosis strains. It works by uniquely inhibiting DNA gyrase, offering a promising new approach to combatting antimicrobial resistance.

Area of Science:

  • Microbiology
  • Natural Product Chemistry
  • Drug Discovery

Background:

  • Tuberculosis remains a leading global infectious disease, with rising multidrug-resistant strains necessitating novel antibiotics.
  • Existing treatments face challenges due to resistance, highlighting the urgent need for new therapeutic strategies with distinct mechanisms of action.

Purpose of the Study:

  • To identify and characterize novel antitubercular compounds from natural sources.
  • To investigate the mechanism of action and structural basis for the activity of corramycin against Mycobacterium tuberculosis.

Main Methods:

  • Screening of a myxobacterial extract library for antitubercular activity.
  • Determination of corramycin's mechanism of action, including its effect on DNA gyrase.
  • Cryo-electron microscopy to elucidate the structural complex of Mycobacterium tuberculosis gyrase and corramycin.

Main Results:

  • Corramycin exhibits potent bactericidal activity against both drug-sensitive and multidrug-resistant Mycobacterium tuberculosis strains.
  • Corramycin induces DNA double-strand breaks by a novel mechanism of DNA gyrase poisoning.
  • Structural analysis reveals corramycin binds to a unique site on DNA gyrase, distinct from fluoroquinolones, overcoming existing resistance.

Conclusions:

  • Corramycin is a promising natural product with potent antitubercular activity and a novel mechanism of action.
  • Its ability to overcome fluoroquinolone resistance makes it a valuable scaffold for developing new antibiotics against tuberculosis.
  • This discovery offers a potential new avenue to address the global crisis of antimicrobial resistance.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...